Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

International Multicenter Study One Day Prevalence Observational Study for Delirium on ICU (IMPROVE-ICU)

This study has been completed.
Sponsor:
Collaborator:
European Society of Intensive Care Medicine
Information provided by (Responsible Party):
Claudia Spies, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01278524
First received: January 18, 2011
Last updated: August 9, 2013
Last verified: August 2013

January 18, 2011
August 9, 2013
January 2011
January 2011   (final data collection date for primary outcome measure)
Implementation rate of routine delirium assessment [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01278524 on ClinicalTrials.gov Archive Site
  • Point prevalence of ICU delirium [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
  • Methodology of delirium assessment (e.g. type of score, frequency of evaluation) [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
  • Non-pharmacological treatment-/prevention strategies [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
  • Drugs used for delirium treatment [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
  • Sedation practices (e.g. scales, daily sedation goals, SBT - spontaneous breathing trials, SAT - spontaneous awakening trials) [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
  • Analgesia regimes (e.g. scales) [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
  • Point prevalence of ICU delirium [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
  • Methodology of delirium assessment (e.g. type of score, frequency of evaluation) [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
  • Non-pharmacological treatment-/prevention strategies [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
  • Drugs used for delirium treatment [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
  • Sedation practices (e.g. scales, daily sedation goals, SBT, SAT) [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
  • Analgesia regimes (e.g. scales) [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
Not Provided
Not Provided
 
International Multicenter Study One Day Prevalence Observational Study for Delirium on ICU
International Multicenter Study One Day Prevalence Observational Study for Delirium on ICU

An anonymous international multicenter - clinical survey, one-day observational study.

Delirium is a serious complication in postoperative and critically ill patients and is independently associated with cognitive impairment at hospital discharge and with significantly higher 6-month mortality. Furthermore, ICU delirium is associated with more days requiring mechanically ventilation, longer ICU length of stay, and longer hospital length of stay. More recently a study by Pisani and co-workers' could show an association between days of delirium and mortality; - each additional day spent in delirium is associated with a 20% increased risk of prolonged hospitalization - translating to over 10 additional days - and a 10% increased risk of death.The reported prevalence of delirium in critically ill patients ranges widely from 11% to 87%. The aim of our study is to investigate the implementation rate of routine delirium assessment in European ICUs.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

ICU patients

Delirium
Not Provided
Critically ill patients
Patients staying in the ICU on the 25th of January
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
1002
January 2011
January 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients staying in the ICU on the 25th of January (one-day prevalence study)

No exclusion Criteria:

Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT01278524
IMPROVE-ICU
No
Claudia Spies, Charite University, Berlin, Germany
Claudia Spies
European Society of Intensive Care Medicine
Study Director: Claudia Spies, MD Charité - Universitaetsmedizin Berlin
Charite University, Berlin, Germany
August 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP